Cantor Fitzgerald Starts Entrada Therapeutics (TRDA) at Overweight

April 1, 2026 6:18 AM EDT Send to a Friend
Cantor Fitzgerald analyst Yanni Souroutzidis initiates coverage on Entrada ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login